<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Acta Naturae</journal-id><journal-title-group><journal-title xml:lang="en">Acta Naturae</journal-title><trans-title-group xml:lang="ru"><trans-title>Acta Naturae</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-8251</issn><publisher><publisher-name xml:lang="en">Acta Naturae Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">10696</article-id><article-id pub-id-type="doi">10.32607/20758251-2011-3-1-77-84</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">A In Vitro and In Vivo Study of the Ability of NOD1 Ligands to Activate the Transcriptional Factor NF-kB</article-title><trans-title-group xml:lang="ru"><trans-title>A In Vitro and In Vivo Study of the Ability of NOD1 Ligands to Activate the Transcriptional Factor NF-kB</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tukhvatulin</surname><given-names>A I</given-names></name><email>amir_tuhvatulin@yahoo.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Logunov</surname><given-names>D Y</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Gitlin</surname><given-names>I I</given-names></name><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name><surname>Shmarov</surname><given-names>M M</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Kudan</surname><given-names>P V</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Adzhieva</surname><given-names>A A</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Moroz</surname><given-names>A F</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Kostyukova</surname><given-names>N N</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Burdelya</surname><given-names>L G</given-names></name><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name><surname>Naroditsky</surname><given-names>B S</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Gintsburg</surname><given-names>A L</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Gudkov</surname><given-names>A V</given-names></name><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Gamaleya Research Institute of Epidemiology and Microbiology, Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru"></institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Roswell Park Cancer Institute, Elm &amp; Carlton Streets, Buffalo, New York, USA</institution></aff><aff><institution xml:lang="ru"></institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2011-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2011</year></pub-date><volume>3</volume><issue>1</issue><issue-title xml:lang="en">VOL 3, NO1 (2011)</issue-title><issue-title xml:lang="ru">ТОМ 3, №1 (2011)</issue-title><fpage>77</fpage><lpage>84</lpage><history><date date-type="received" iso-8601-date="2020-01-17"><day>17</day><month>01</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2011, Tukhvatulin A.I., Logunov D.Y., Gitlin I.I., Shmarov M.M., Kudan P.V., Adzhieva A.A., Moroz A.F., Kostyukova N.N., Burdelya L.G., Naroditsky B.S., Gintsburg A.L., Gudkov A.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2011, Tukhvatulin A.I., Logunov D.Y., Gitlin I.I., Shmarov M.M., Kudan P.V., Adzhieva A.A., Moroz A.F., Kostyukova N.N., Burdelya L.G., Naroditsky B.S., Gintsburg A.L., Gudkov A.V.</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="en">Tukhvatulin A.I., Logunov D.Y., Gitlin I.I., Shmarov M.M., Kudan P.V., Adzhieva A.A., Moroz A.F., Kostyukova N.N., Burdelya L.G., Naroditsky B.S., Gintsburg A.L., Gudkov A.V.</copyright-holder><copyright-holder xml:lang="ru">Tukhvatulin A.I., Logunov D.Y., Gitlin I.I., Shmarov M.M., Kudan P.V., Adzhieva A.A., Moroz A.F., Kostyukova N.N., Burdelya L.G., Naroditsky B.S., Gintsburg A.L., Gudkov A.V.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://actanaturae.ru/2075-8251/article/view/10696">https://actanaturae.ru/2075-8251/article/view/10696</self-uri><abstract xml:lang="en"><p/></abstract><trans-abstract xml:lang="ru"><p>Pattern-recognition receptors (PRR) play a crucial role in the induction of the defense reactions of the immune system against pathogenic bacterial and viral infections. The activation of PRR by specific, highly conserved pathogen-associated molecular patterns (PAMPs) induces numerous immune reactions related both to innate and adaptive immunity. In addition to the well-studied Toll-like receptors, pathogens can be recognized by the receptors belonging to the other PRR families; including NOD-like receptors (NLR). Stimulation of members of NOD-like receptors (NOD1, 2) and Toll-like receptors results in the activation of the transcriptional factor NF-kB regulating gene expression in numerous molecules implicated in the development of proinflammatory reactions. As opposed to Toll-like receptors, the NF-kB-activating ability of NLRs has not been fully studied. In this work, we examine the ability of one member of the NLR family - NOD1 - to activate the main proinflammatory transcriptional factor NF-kB. We also compare the NF-kB-activating ability of NOD1 ligands of a different structure with TLR4,5 ligands in vitro and in vivo.</p></trans-abstract><kwd-group xml:lang="en"><kwd>pattern-recognition receptors</kwd><kwd>Toll-like receptors</kwd><kwd>NODl-receptor</kwd><kwd>transcriptional factor NF-kB</kwd><kwd>peptidoglycan of gram-negative bacteria</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Medzhitov R., Janeway C. Jr. // Trends Microbiol. 2000. V. 10. P. 3452-3456.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Kishore U. Target Pattern Recognition in Innate Immunity. Springer Science +Business Media, LLC Landes Bioscience, 2009. 202 p.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Hayden M.S., West A.P, Ghosh S. // Oncogene. 2006. V. 51. P. 6758-6780.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Carmody R.J., Chen Y.H. // Cell. Mol. Immunol. 2007. V. 1. P. 31-41.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Gill N., Davies E.J., Ashkar A.A. // Am. J. Reprod. Immunol. 2008. V. 59. P. 35-43.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Borsutzky S., Kretschmer K., Becker P.D., Muhlradt P.F., Kirschning C.J., Weiss S., Guzman C.A. // J. Immunol. 2005. V. 174. P. 6308-6313.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Weeratna R.D., Makinen S.R., McCluskie M.J., Davis H.L. // Vaccine. 2005. V. 45. P 5263-5270.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Warren S.E., Mao D.P., Rodriguez A.E., Miao E.A., Aderem A. // J. Immunol. 2008. V. 180. P 7558-7564.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Burdelya L.G., Krivokrysenko V.I., Tallant T.C., Strom E., Gleiberman A.S., Gupta D., Kurnasov O.V., Fort F.L., terized by a lower reactogenecity in comparison with some TLR ligands (e.g., LPS). Such adjuvants could be used together with vaccine antigens for protection against different pathogens, including intracellular ones. In order to bolster this hypothesis further, a detailed analysis of the individual immune responses that are initiated by the activation of NOD receptors is required. • Osterman A.L., Didonato J.A., et al. // Science. 2008. V. 5873. P. 226-230.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Girardin S.E., Boneca I.G., Carneiro L.A., Antignac A., Jéhanno M., Viala J., Tedin K., Taha M.K., Labigne A., Zahringer U., et al. // Science. 2003. V. 5625. P 1584-1587.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Zhao L., Kwon M.J., Huang S., Lee J.Y., Fukase K., Inohara N., Hwang D.H. // J. Biol. Chem. 2007. V. 282. P 11618-11628.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Alexander G., Carlsen H., Blomhoff R. // Invest. Ophthalmol. Vis. Sci. 2003. V. 44. P. 2683-2688.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Carlsen H., Moskaug J.O., Fromm S.H., Blomhoff R. // J. Immunol. 2002. V. 168. P. 1441-1446.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Ho T.Y., Chen Y.S., Hsiang C.Y. // Biomaterials. 2007. V. 30. P. 4370-4377.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Austenaa L.M., Carlsen H., Hollung K., Blomhoff H.K., Blomhoff R. //J. Nutr. Biochem. 2009. V. 20. P 726-734.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Pruett S.B., Fan R. // BMC Immunol. 2009. Doi 10.1186/1471-2172-10-49.</mixed-citation></ref></ref-list></back></article>
